Market Tracker

03/30 12:17pm ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.55
Delayed Data
As of 12:01pm ET
 -0.1199 / -1.56%
Today’s Change
3.79
Today|||52-Week Range
9.35
+41.12%
Year-to-Date

Today’s Trading

Previous close7.67
Today’s open7.85
Day’s range7.46 - 7.89
Volume185,750
Average volume (3 months)557,702
Market cap$471.7M
Dividend yield--
Data as of 12:01pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IGIGI Laboratories Inc-0.24-2.74%
MRTXMirati Therapeutics ...+0.75+2.64%
RVNCRevance Therapeutics...+0.09+0.47%
XNPTXenoport Inc+0.01+0.14%
Data as of 12:14pm ET, 03/30/2015

Financials

Last reporting dateMarch 30, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts